Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00941889 · ClinicalTrials.gov registry record · NA
The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT00941889 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 32 participants.
The verdict
NCT00941889, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The primary objective of this pilot study is to evaluate the effect of the HPV vaccine Gardasil on anal condylomata recurrence and persistence rates in HIV positive patients.
Interventions
- DRUG Saline
- DRUG Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2007-07 |
| Est. Completion | 2011-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00941889
The ClinicalTrials.gov registry entry for NCT00941889 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT00941889 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00941889 about?
NCT00941889 is a clinical study titled "The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata". The primary objective of this pilot study is to evaluate the effect of the HPV vaccine Gardasil on anal condylomata recurrence and persistence rates in HIV positive patients.
What is the current status of trial NCT00941889?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2007-07. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00941889?
The interventions under investigation include: Saline (DRUG), Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine (DRUG).
Who is sponsoring clinical trial NCT00941889?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.